scispace - formally typeset
Open AccessJournal ArticleDOI

Structural evolution of C-terminal domains in the p53 family.

Reads0
Chats0
TLDR
These structures show a potential path of evolution from an ancestral dimeric form over a tetrameric form, with additional stabilization elements, to the tetramerization domain of mammalian p53.
Abstract
The tetrameric state of p53, p63, and p73 has been considered one of the hallmarks of this protein family. While the DNA binding domain (DBD) is highly conserved among vertebrates and invertebrates, sequences C-terminal to the DBD are highly divergent. In particular, the oligomerization domain (OD) of the p53 forms of the model organisms Caenorhabditis elegans and Drosophila cannot be identified by sequence analysis. Here, we present the solution structures of their ODs and show that they both differ significantly from each other as well as from human p53. CEP-1 contains a composite domain of an OD and a sterile alpha motif (SAM) domain, and forms dimers instead of tetramers. The Dmp53 structure is characterized by an additional N-terminal β-strand and a C-terminal helix. Truncation analysis in both domains reveals that the additional structural elements are necessary to stabilize the structure of the OD, suggesting a new function for the SAM domain. Furthermore, these structures show a potential path of evolution from an ancestral dimeric form over a tetrameric form, with additional stabilization elements, to the tetramerization domain of mammalian p53.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Structural Biology of the Tumor Suppressor p53

TL;DR: In this review, insights are provided into the structural complexity of p53, the molecular mechanisms of its inactivation in cancer, and therapeutic strategies for the pharmacological rescue of p 53 function in tumors.
Journal ArticleDOI

The p53 Pathway: Origins, Inactivation in Cancer, and Emerging Therapeutic Approaches

TL;DR: The structural evolution of the p53 pathway is traced, from germ-line surveillance in simple multicellular organisms to its pluripotential role in humans, and some of these compounds have now moved from proof-of-concept studies into clinical trials, with prospects for further, personalized anticancer medicines.
Journal ArticleDOI

The tumor suppressor p53: from structures to drug discovery.

TL;DR: Key structural aspects of p53 function and its inactivation by oncogenic mutations are discussed, including targeting mutant-specific lesions on the surface of destabilized cancer mutants with small molecules and selective inhibition of p 53's degradative pathways.
Journal ArticleDOI

p63 and p73, the Ancestors of p53

TL;DR: The contribution of p63 and p73 to human pathology with emphasis on their roles in tumorigenesis and development is described.
Journal ArticleDOI

The Origins and Evolution of the p53 Family of Genes

TL;DR: A common ancestor to the three p53 family members of human genes p53, p63, and p73 is first detected in the evolution of modern-day sea anemones, in which both structurally and functionally it acts to protect the germ line from genomic instabilities in response to stresses.
References
More filters
Journal ArticleDOI

WAF1, a potential mediator of p53 tumor suppression

TL;DR: A gene is identified, named WAF1, whose induction was associated with wild-type but not mutant p53 gene expression in a human brain tumor cell line and that could be an important mediator of p53-dependent tumor growth suppression.
Journal ArticleDOI

MOLMOL: a program for display and analysis of macromolecular structures.

TL;DR: Special efforts were made to allow for appropriate display and analysis of the sets of typically 20-40 conformers that are conventionally used to represent the result of an NMR structure determination, using functions for superimposing sets of conformers, calculation of root mean square distance (RMSD) values, identification of hydrogen bonds, and identification and listing of short distances between pairs of hydrogen atoms.
Journal ArticleDOI

Size-Distribution Analysis of Macromolecules by Sedimentation Velocity Ultracentrifugation and Lamm Equation Modeling

TL;DR: A new method for the size-distribution analysis of polymers by sedimentation velocity analytical ultracentrifugation that exploits the ability of Lamm equation modeling to discriminate between the spreading of the sedimentation boundary arising from sample heterogeneity and from diffusion is described.
Journal ArticleDOI

A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia

TL;DR: Three participants are identified (AT gene(s), p53, and GADD45) in a signal transduction pathway that controls cell cycle arrest following DNA damage; abnormalities in this pathway probably contribute to tumor development.
Related Papers (5)